Investors and Media
Scholar Rock to Present at the Jefferies Global Healthcare Conference
Main content section
Scholar Rock to Present at the Jefferies Global Healthcare Conference
A live webcast of the events may be accessed by visiting the Investors & Media section of the
About
This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies,
Scholar Rock® is a registered trademark of
Availability of Other Information About Scholar Rock
Investors and others should note that we communicate with our investors and the public using our company website www.scholarrock.com, including, but not limited to, company disclosures, investor presentations and FAQs,
View source version on businesswire.com: https://www.businesswire.com/news/home/20250528248244/en/
Investors & Media
Rushmie Nofsinger
rnofsinger@scholarrock.com
ir@scholarrock.com
857-259-5573
Source: